Français
ItalianoBond GSK PLC 6.375% ( US377372AE71 ) in USD
| Issuer | GSK PLC | ||||||||||
| Market price |  113.71 % ▲ |
||||||||||
| Country |  United Kingdom
|
||||||||||
| ISIN code |
 US377372AE71 ( in USD )
|
||||||||||
| Interest rate | 6.375% per year ( payment 2 times a year) | ||||||||||
| Maturity | 15/05/2038 | ||||||||||
|
Prospectus brochure in PDF format |
|||||||||||
| Minimal amount | 2 000 USD | ||||||||||
| Total amount | 2 750 000 000 USD | ||||||||||
| Cusip | 377372AE7 | ||||||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 15/11/2026 ( In 60 days ) | ||||||||||
| Detailed description |
GSK PLC is a British multinational pharmaceutical and biopharmaceutical company headquartered in Brentford, UK, focused on research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products globally. GSK PLC issued a USD 2,750,000,000 bond (ISIN: US377372AE71, CUSIP: 377372AE7) maturing May 15, 2038, with a 6.375% coupon rate, paying semi-annually, currently trading at 100% of par, minimum purchase 2000, rated A by S&P and A2 by Moody's. |
||||||||||
| |||||||||||